1 |
Feng Y, Cai H, Zhao H, Zhang X, Wang L, Cai L, Wang W, Shan Y, Wang W. Molecular mechanism of Panax ginseng C. A. Meyer against renal fibrosis based on network pharmacology and molecular docking analysis.. [DOI: 10.21203/rs.3.rs-2661141/v1] [Reference Citation Analysis]
|
2 |
Wang Q, Li W, Hu H, Lu X, Qin S. Monomeric compounds from traditional Chinese medicine: New hopes for drug discovery in pulmonary fibrosis. Biomed Pharmacother 2023;159:114226. [PMID: 36657302 DOI: 10.1016/j.biopha.2023.114226] [Reference Citation Analysis]
|
3 |
Fan M, Lan X, Wang Q, Shan M, Fang X, Zhang Y, Wu D, Luo H, Gao W, Zhu D. Renal function protection and the mechanism of ginsenosides: Current progress and future perspectives. Front Pharmacol 2023;14:1070738. [PMID: 36814491 DOI: 10.3389/fphar.2023.1070738] [Reference Citation Analysis]
|
4 |
Dong X, Kong L, Huang L, Su Y, Li X, Yang L, Ji P. Ginsenoside Rg1 treatment protects against cognitive dysfunction via inhibiting PLC–CN–NFAT1 signaling in T2DM mice. Journal of Ginseng Research 2022. [DOI: 10.1016/j.jgr.2022.12.006] [Reference Citation Analysis]
|
5 |
Yang S, Pei T, Wang L, Zeng Y, Li W, Yan S, Xiao W, Cheng W. Salidroside Alleviates Renal Fibrosis in SAMP8 Mice by Inhibiting Ferroptosis. Molecules 2022;27. [PMID: 36432138 DOI: 10.3390/molecules27228039] [Reference Citation Analysis]
|
6 |
Yang S, Wang J, Cheng P, Chen L, Hu J, Zhu G. Ginsenoside Rg1 in neurological diseases: From bench to bedside. Acta Pharmacol Sin 2022. [DOI: 10.1038/s41401-022-01022-1] [Reference Citation Analysis]
|
7 |
Zhang JJ, Chen KC, Zhou Y, Wei H, Qi MH, Wang Z, Zheng YN, Chen RX, Liu S, Li W. Evaluating the effects of mitochondrial autophagy flux on ginsenoside Rg2 for delaying D-galactose induced brain aging in mice. Phytomedicine 2022;104:154341. [PMID: 35870376 DOI: 10.1016/j.phymed.2022.154341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
8 |
Xiao L, Wang M, Zou K, Li Z, Luo J. Effects of ginsenoside Rg1 on proliferation and directed differentiation of human umbilical cord mesenchymal stem cells into neural stem cells. NeuroReport 2022;33:413-421. [DOI: 10.1097/wnr.0000000000001795] [Reference Citation Analysis]
|
9 |
Liu Y, Xu X, Lei W, Hou Y, Zhang Y, Tang R, Yang Z, Tian Y, Zhu Y, Wang C, Deng C, Zhang S, Yang Y. The NLRP3 inflammasome in fibrosis and aging: The known unknowns. Ageing Res Rev 2022;79:101638. [PMID: 35525426 DOI: 10.1016/j.arr.2022.101638] [Reference Citation Analysis]
|
10 |
Peng Y, Li Y, Li H, Yu J. Shikonin attenuates kidney tubular epithelial cells apoptosis, oxidative stress, and inflammatory response through nicotinamide adenine dinucleotide phosphate oxidase 4/PTEN pathway in acute kidney injury of sepsis model. Drug Dev Res 2022. [PMID: 35417044 DOI: 10.1002/ddr.21936] [Reference Citation Analysis]
|
11 |
Cao B, Zeng M, Si Y, Zhang B, Wang Y, Xu R, Huang Y, Feng W, Zheng X. Extract of Corallodiscus flabellata attenuates renal fibrosis in SAMP8 mice via the Wnt/β-catenin/RAS signaling pathway. BMC Complement Med Ther 2022;22:52. [PMID: 35227255 DOI: 10.1186/s12906-022-03535-y] [Reference Citation Analysis]
|
12 |
Li Y, Zhang D, Li L, Han Y, Dong X, Yang L, Li X, Li W, Li W. Ginsenoside Rg1 ameliorates aging‑induced liver fibrosis by inhibiting the NOX4/NLRP3 inflammasome in SAMP8 mice. Mol Med Rep 2021;24:801. [PMID: 34523690 DOI: 10.3892/mmr.2021.12441] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
13 |
Mvubu NE, Chiliza TE. Exploring the Use of Medicinal Plants and Their Bioactive Derivatives as Alveolar NLRP3 Inflammasome Regulators during Mycobacterium tuberculosis Infection. Int J Mol Sci 2021;22:9497. [PMID: 34502407 DOI: 10.3390/ijms22179497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
14 |
Zhang Y, Ding S, Chen Y, Sun Z, Zhang J, Han Y, Dong X, Fang Z, Li W. Ginsenoside Rg1 alleviates lipopolysaccharide-induced neuronal damage by inhibiting NLRP1 inflammasomes in HT22 cells. Exp Ther Med 2021;22:782. [PMID: 34055081 DOI: 10.3892/etm.2021.10214] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
15 |
Zhou S, Zhou Y, Yu J, Jiang L, Xiang Y, Wang J, Du Y, Cui X, Ge F. A neutral polysaccharide from Ophiocordyceps lanpingensis restrains cisplatin-induced nephrotoxicity. Food Sci Nutr 2021;9:3602-16. [PMID: 34262721 DOI: 10.1002/fsn3.2317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
16 |
Chen TT, Xiao F, Li N, Shan S, Qi M, Wang ZY, Zhang SN, Wei W, Sun WY. Inflammasome as an Effective Platform for Fibrosis Therapy. J Inflamm Res 2021;14:1575-90. [PMID: 33907438 DOI: 10.2147/JIR.S304180] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
17 |
Pan H, Feng W, Chen M, Luan H, Hu Y, Zheng X, Wang S, Mao Y. Alginate Oligosaccharide Ameliorates D-Galactose-Induced Kidney Aging in Mice through Activation of the Nrf2 Signaling Pathway. Biomed Res Int 2021;2021:6623328. [PMID: 33506023 DOI: 10.1155/2021/6623328] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
18 |
Ding N, Wei B, Fu X, Wang C, Wu Y. Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis. Front Pharmacol 2020;11:591393. [PMID: 33390969 DOI: 10.3389/fphar.2020.591393] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
19 |
Cheng CY, Vo TTT, Lin WN, Huang HW, Chuang CC, Chu PM, Lee IT. Nrf2/HO-1 partially regulates cytoprotective effects of carbon monoxide against urban particulate matter-induced inflammatory responses in oral keratinocytes. Cytokine 2020;133:155185. [PMID: 32615411 DOI: 10.1016/j.cyto.2020.155185] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|